Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.

Le T, Cherry JD, Chang SJ, Knoll MD, Lee ML, Barenkamp S, Bernstein D, Edelman R, Edwards KM, Greenberg D, Keitel W, Treanor J, Ward JI; APERT Study.

J Infect Dis. 2004 Aug 1;190(3):535-44. Epub 2004 Jul 7.

PMID:
15243929
2.

Acellular pertussis vaccines and the role of pertactin and fimbriae.

Poolman JT, Hallander HO.

Expert Rev Vaccines. 2007 Feb;6(1):47-56. Review.

PMID:
17280478
3.

Acellular pertussis vaccine for adolescents.

de Carvalho AP, Pereira EM.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S15-24. Epub 2006 Jun 16. Review.

4.

Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.

Taranger J, Trollfors B, Bergfors E, Knutsson N, Lagergård T, Schneerson R, Robbins JB.

Pediatrics. 2001 Dec;108(6):E115. Review.

PMID:
11731642
5.

How to make sense of pertussis immunogenicity data.

Olin P, Hallander HO, Gustafsson L, Reizenstein E, Storsaeter J.

Clin Infect Dis. 2001 Dec 15;33 Suppl 4:S288-91. Review.

PMID:
11709761
6.

[Acellular pertussis vaccine].

Wiedermann G, Ambrosch F, Vanura H.

Wien Med Wochenschr. 1991;141(12):270-2. Review. German.

PMID:
1949820
7.

Immunogenicity of a two-component (PT & FHA) acellular pertussis vaccine in various combinations.

Vidor E, Plotkin SA.

Hum Vaccin. 2008 Sep-Oct;4(5):328-40. Epub 2008 Sep 2. Review.

PMID:
18398308
8.

Pertussis: current concepts of pathogenesis and prevention.

Hewlett EL.

Pediatr Infect Dis J. 1997 Apr;16(4 Suppl):S78-84. Review.

PMID:
9109161
9.

Acellular pertussis vaccines for adolescents.

Pichichero ME, Casey JR.

Pediatr Infect Dis J. 2005 Jun;24(6 Suppl):S117-26. Review.

PMID:
15931139
10.
11.

Acellular pertussis vaccines--a solution to the pertussis problem.

Cherry JD.

J Infect Dis. 1993 Jul;168(1):21-4. Review.

PMID:
8515111
12.

Acellular pertussis vaccines in adults.

Keitel WA, Edwards KM.

Infect Dis Clin North Am. 1999 Mar;13(1):83-94, vi. Review.

PMID:
10198793
13.

[Laboratory diagnosis of pertussis. Role of serology].

Sanz Moreno JC, De Ory Manchón F, González Alonso J, de La Torre JL, Salmerón F, Limia A, Tello O, Pachón I, Amela C, Vázquez J, de Ory F, Sanz JC; Grupo de Trabajo sobre Tos Ferina.

Enferm Infecc Microbiol Clin. 2002 May;20(5):212-8. Review. Spanish.

PMID:
12006259
14.

Differences by antigen in seroconversion: sensitivity, specificity and bias in the serological confirmation of pertussis.

Wassilak SG, Anemona A, Giuliano M, Giammanco A.

Dev Biol Stand. 1997;89:221-8. Review.

PMID:
9272354
15.

Pertussis: an important target for maternal immunization.

Edwards KM.

Vaccine. 2003 Jul 28;21(24):3483-6. Review.

PMID:
12850365
16.

Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity.

Kerr JR, Matthews RC.

Eur J Clin Microbiol Infect Dis. 2000 Feb;19(2):77-88. Review.

PMID:
10746492
17.

Immunoprophylaxis in pertussis.

Deb M.

J Commun Dis. 1984 Mar;16(1):54-60. Review.

PMID:
12055788
18.

Pertussis: an old disease that is still with us.

Heininger U.

Curr Opin Infect Dis. 2001 Jun;14(3):329-35. Review.

PMID:
11964852
19.

The acellular pertussis vaccine trials: an interpretation.

Plotkin SA, Cadoz M.

Pediatr Infect Dis J. 1997 May;16(5):508-17; discussion 517-9. Review. No abstract available.

PMID:
9154547

Supplemental Content

Support Center